Bedford, Mass., Nov. 29 (Korea Bizwire) - Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen's bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of [...]The post Conagen Develops High-purity Non-GMO Sulforaphane by Bioconversion appeared first on Be Korea-savvy.
Conagen is a Massachusetts-based biotechnology company that develops synthetic biology solutions for food, pharmaceutical, and renewable materials industries.